Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.

Protein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly...

Full description

Bibliographic Details
Main Authors: Esther Gies, Inga Wilde, Jason M Winget, Maria Brack, Barak Rotblat, Carolina Arias Novoa, Aruna D Balgi, Poul H Sorensen, Michel Roberge, Thibault Mayor
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-12-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3009716?pdf=render
_version_ 1818138057194340352
author Esther Gies
Inga Wilde
Jason M Winget
Maria Brack
Barak Rotblat
Carolina Arias Novoa
Aruna D Balgi
Poul H Sorensen
Michel Roberge
Thibault Mayor
author_facet Esther Gies
Inga Wilde
Jason M Winget
Maria Brack
Barak Rotblat
Carolina Arias Novoa
Aruna D Balgi
Poul H Sorensen
Michel Roberge
Thibault Mayor
author_sort Esther Gies
collection DOAJ
description Protein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly clear long-lived and poorly soluble proteins. Both systems are interconnected and, in some instances, autophagy can redirect proteasome substrates to the lysosomes.To better understand the interplay between these two systems, we established a neuroblastoma cell population stably expressing the GFP-ubiquitin fusion protein. We show that inhibition of the proteasome leads to the formation of large ubiquitin-containing inclusions accompanied by lower solubility of the ubiquitin conjugates. Strikingly, the formation of the ubiquitin-containing aggregates does not require ectopic expression of disease-specific proteins. Moreover, formation of these focused inclusions caused by proteasome inhibition requires the lysine 63 (K63) of ubiquitin. We then assessed selected compounds that stimulate autophagy and found that the antihelmintic chemical niclosamide prevents large aggregate formation induced by proteasome inhibition, while the prototypical mTORC1 inhibitor rapamycin had no apparent effect. Niclosamide also precludes the accumulation of poly-ubiquitinated proteins and of p62 upon proteasome inhibition. Moreover, niclosamide induces a change in lysosome distribution in the cell that, in the absence of proteasome activity, may favor the uptake into lysosomes of ubiquitinated proteins before they form large aggregates.Our results indicate that proteasome inhibition provokes the formation of large ubiquitin containing aggregates in tissue culture cells, even in the absence of disease specific proteins. Furthermore our study suggests that the autophagy-inducing compound niclosamide may promote the selective clearance of ubiquitinated proteins in the absence of proteasome activity.
first_indexed 2024-12-11T10:06:08Z
format Article
id doaj.art-8e454627f8be412ea9dfa3b3fc94675f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T10:06:08Z
publishDate 2010-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8e454627f8be412ea9dfa3b3fc94675f2022-12-22T01:11:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-12-01512e1441010.1371/journal.pone.0014410Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.Esther GiesInga WildeJason M WingetMaria BrackBarak RotblatCarolina Arias NovoaAruna D BalgiPoul H SorensenMichel RobergeThibault MayorProtein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly clear long-lived and poorly soluble proteins. Both systems are interconnected and, in some instances, autophagy can redirect proteasome substrates to the lysosomes.To better understand the interplay between these two systems, we established a neuroblastoma cell population stably expressing the GFP-ubiquitin fusion protein. We show that inhibition of the proteasome leads to the formation of large ubiquitin-containing inclusions accompanied by lower solubility of the ubiquitin conjugates. Strikingly, the formation of the ubiquitin-containing aggregates does not require ectopic expression of disease-specific proteins. Moreover, formation of these focused inclusions caused by proteasome inhibition requires the lysine 63 (K63) of ubiquitin. We then assessed selected compounds that stimulate autophagy and found that the antihelmintic chemical niclosamide prevents large aggregate formation induced by proteasome inhibition, while the prototypical mTORC1 inhibitor rapamycin had no apparent effect. Niclosamide also precludes the accumulation of poly-ubiquitinated proteins and of p62 upon proteasome inhibition. Moreover, niclosamide induces a change in lysosome distribution in the cell that, in the absence of proteasome activity, may favor the uptake into lysosomes of ubiquitinated proteins before they form large aggregates.Our results indicate that proteasome inhibition provokes the formation of large ubiquitin containing aggregates in tissue culture cells, even in the absence of disease specific proteins. Furthermore our study suggests that the autophagy-inducing compound niclosamide may promote the selective clearance of ubiquitinated proteins in the absence of proteasome activity.http://europepmc.org/articles/PMC3009716?pdf=render
spellingShingle Esther Gies
Inga Wilde
Jason M Winget
Maria Brack
Barak Rotblat
Carolina Arias Novoa
Aruna D Balgi
Poul H Sorensen
Michel Roberge
Thibault Mayor
Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
PLoS ONE
title Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
title_full Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
title_fullStr Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
title_full_unstemmed Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
title_short Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition.
title_sort niclosamide prevents the formation of large ubiquitin containing aggregates caused by proteasome inhibition
url http://europepmc.org/articles/PMC3009716?pdf=render
work_keys_str_mv AT esthergies niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT ingawilde niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT jasonmwinget niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT mariabrack niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT barakrotblat niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT carolinaariasnovoa niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT arunadbalgi niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT poulhsorensen niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT michelroberge niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition
AT thibaultmayor niclosamidepreventstheformationoflargeubiquitincontainingaggregatescausedbyproteasomeinhibition